Journal for ImmunoTherapy of Cancer

Correction: Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003154corr1; DOI: 10.1136/jitc-2021-003154corr1
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Meredith M Regan, Charlene M Mantia, Lillian Werner, Ahmad A Tarhini, James Larkin, F Stephen Hodi, Jedd Wolchok, Michael A Postow, Brian Stwalley, Andriy Moshyk, Corey Ritchings, Sandra Re, Wim van Dijck, David F McDermott, Michael B Atkins

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003743; DOI: 10.1136/jitc-2021-003743
Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity
Shunichi Taki, Kohei Matsuoka, Yuko Nishinaga, Kazuomi Takahashi, Hirotoshi Yasui, Chiaki Koike, Misae Shimizu, Mitsuo Sato, Kazuhide Sato

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (11) e003036; DOI: 10.1136/jitc-2021-003036
Correction: Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML
Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002968corr1; DOI: 10.1136/jitc-2021-002968corr1
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study
Ryan Sun, Zachary McCaw, Lu Tian, Hajime Uno, Fangxin Hong, Dae Hyun Kim, Lee-Jen Wei

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003323; DOI: 10.1136/jitc-2021-003323
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003005corr1; DOI: 10.1136/jitc-2021-003005corr1
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
Oliver Klein, Damien Kee, Bo Gao, Ben Markman, Jessica da Gama Duarte, Luke Quigley, Louise Jackett, Richelle Linklater, Andrew Strickland, Clare Scott, Linda Mileshkin, Jodie Palmer, Matteo Carlino, Andreas Behren, Jonathan Cebon

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003156; DOI: 10.1136/jitc-2021-003156
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
Yasmin Nouri, Robert Weinkove, Rachel Perret

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003065; DOI: 10.1136/jitc-2021-003065
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
Yu-Chao Zhu, Hany M Elsheikha, Jian-Hua Wang, Shuai Fang, Jun-Jun He, Xing-Quan Zhu, Jia Chen

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (11) e002970; DOI: 10.1136/jitc-2021-002970
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Shaoming Zhu, A-Hong Ma, Zheng Zhu, Elio Adib, Ting Rao, Na Li, Kaiyuan Ni, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Juan Garisto Risco, David Kwiatkowski, Kent Mouw, Guru Sonpavde, Fan Cheng, Chong-xian Pan

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002917; DOI: 10.1136/jitc-2021-002917

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages